Framework for the Supply of Radiopharmaceuticals and Related Consumables 2023

Complete

Buyers

Value

£100,000,000

Classifications

  • Radio-isotopes

Tags

  • tender

Submission Deadline

1 year ago

Published

1 year ago

Description

HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases.  

The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

Open

H3AT ADS

The Supply of an ADS equipment package to be supplied into the Hydrogen-3 Advanced Technology Facility at UKAEA’s Culham Campus. The scope of work is expected to be delivered, installed, and commissioned within an estimated duration of 36 months. Sub-system Package – the package scope of work includes design, manufacture, assembly, Factory Acceptance Testing, delivery, supply, installation, Site Acceptance Testing and commissioning.

United Kingdom Atomic Energy Authority

United Kingdom Atomic Energy Authority

Published 3 weeks ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

HealthTrust Europe LLP (HTE) acting on behalf of

Body governed by public law

Ian MacKinnon

[email protected]

447818562338

Timeline complete